|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Sosei_Group_Corporation
|
|
gptkbp:acquisitionYear
|
2015
|
|
gptkbp:collaboratedWith
|
gptkb:Pfizer
gptkb:Allergan
gptkb:AstraZeneca
gptkb:Teva_Pharmaceutical_Industries
gptkb:Takeda_Pharmaceutical_Company
|
|
gptkbp:country
|
gptkb:United_Kingdom
|
|
gptkbp:focus
|
gptkb:G_protein-coupled_receptors_(GPCRs)
|
|
gptkbp:foundedYear
|
2007
|
|
gptkbp:founder
|
gptkb:Fiona_Marshall
Malcolm Weir
|
|
gptkbp:headquartersLocation
|
gptkb:Hertfordshire,_United_Kingdom
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:parentCompany
|
gptkb:Sosei_Group_Corporation
|
|
gptkbp:productType
|
drug discovery
|
|
gptkbp:technology
|
StaR technology
|
|
gptkbp:website
|
https://www.heptares.com/
|
|
gptkbp:bfsParent
|
gptkb:SV_Health_Investors
gptkb:Novartis_Venture_Fund
gptkb:Sosei_Heptares
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Heptares Therapeutics
|